Pulmonx Corporation (NASDAQ: LUNG) is one of the best stocks under $3 to invest in. On October 28, Lake Street lowered the ...
Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...
Glen French, member of the Board of Directors and former Pulmonx President and Chief Executive Officer, reappointed President and Chief Executive ...
Medtronic today announced the first results from the high cardiovascular risk cohort of its SPYRAL AFFIRM study.
NHTSA investigates GM L87 6.2L V8 engine failures in trucks not included in the recent recall. The probe addresses 173 reports of bearing failure.
The saphenous vein grafts treated in the RCT were relatively straightforward, while the native vessels were largely CTOs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback